HIGHLIGHTS
- who: October et al. from the Alam, Malaysia Zhejiang University, China have published the paper: The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions, in the Journal: (JOURNAL)
- what: Severe CRS can easily lead to severe multi-organ system toxicity, which is one of the main reasons limiting the safe application of CAR-T therapy. The target antigen of CAR-T therapy is key to treating cancer and is the main reason for target or off-target effects.
- how: The results showed that patients could benefit from early . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.